KURA FY 2019 Earnings — Kura Oncology, Inc. Revenue & Financial Results | Market Cap Arena

KURAKura Oncology, Inc.

$774M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$67M

Net Income

-$63M

EPS (Diluted)

$-1.51

Cash Flow

Operating Cash Flow

-$55M

Free Cash Flow

-$55M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$242M

Total Liabilities

$23M

Stockholders' Equity

$219M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$10,000	+100.0%
Operating Income	-$67M	-$63M	-7.3%
Net Income	-$63M	-$60M	-4.5%